It is the intake evaluation that matches the dose to the injury, the compounding pharmacy relationship that guarantees the product quality, and the mid-cycle check-in that catches suboptimal response before the full cycle is wasted
By creating an account or purchasing from our website, you acknowledge and agree to be bound by these Terms of Use and the full Terms & Conditions
Levels greater than 7 ng/mL and 13 ng/mL may be needed to optimally prevent elevated homocysteine and neural tube defects, respectively, per some research
The 2026 FDA Update What Happened Before In 2023 and 2024, the FDA told pharmacies to stop making BPC157 and TB500 because there was not enough safety data
So even though any professional athlete with this substance in their system would be automatically disqualified from competition, and the FDA put out advisories about the issues with compounding pharmacies making these substances (6,7), people are still getting their hands on BPC 157